Cost‐effectiveness and budget impact of whole blood pathogen reduction in Ghana

Transfusion ◽  
2021 ◽  
Author(s):  
W. Alton Russell ◽  
Shirley Owusu‐Ofori ◽  
Alex Owusu‐Ofori ◽  
Eileen Micah ◽  
Betty Norman ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Whole Blood ◽  
Budget Impact ◽  
Pathogen Reduction

scholarly journals PIN150 Economic VALUE of Treatment and Vaccine Technologies to Address the COVID-19 Pandemic: A Cost-Effectiveness and Budget IMPACT Analysis

2020 ◽  
Vol 23 ◽  
pp. S568
Author(s):  
W. Padula ◽  
S. Malaviya ◽  
N. Reid ◽  
F. Chingcuanco ◽  
J. Ballreich ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Impact Analysis ◽  
Budget Impact ◽  
Economic Value ◽  
Budget Impact Analysis

scholarly journals Remodelling whole blood processing through automation and pathogen reduction technology at the Luxembourg Red Cross

2021 ◽  
pp. 103195
Author(s):  
Nicolas Malvaux ◽  
Anne Schuhmacher ◽  
Fanette Defraigne ◽  
Remy Jacob ◽  
Aicha Bah ◽  
...  
Keyword(s):  
Whole Blood ◽  
Red Cross ◽  
Blood Processing ◽  
Pathogen Reduction

scholarly journals Implantable Cardiac Monitor Compared with Conventional Diagnostic for Unexplained Syncope: A Combined Cost-Effectiveness and Budget-Impact Analysis

2018 ◽  
Vol 21 ◽  
pp. S166
Author(s):  
RC Lucchetta ◽  
BS Riveros ◽  
MP Rosim ◽  
P Holanda ◽  
M Melo ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis ◽  
Cardiac Monitor ◽  
Unexplained Syncope ◽  
Implantable Cardiac Monitor

scholarly journals PCN99 THE COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF RITUXIMAB(HANLIKANG) FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN CHINA

2019 ◽  
Vol 22 ◽  
pp. S455
Author(s):  
M.M. Zhao ◽  
Y. Xiang ◽  
W. Juying ◽  
S.H. Jia ◽  
B.B. Chen ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
B Cell ◽  
Impact Analysis ◽  
Budget Impact ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Budget Impact Analysis ◽  
Large B Cell Lymphoma ◽  
The Cost ◽  
Large B Cell

scholarly journals Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective

2018 ◽  
Vol Volume 10 ◽  
pp. 791-803 ◽  
Author(s):  
Dhvani Shah ◽  
Nancy A Risebrough ◽  
Johnna Perdrizet ◽  
Neeraj N Iyer ◽  
Cory Gamble ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cardiovascular Risk ◽  
Cost Effectiveness ◽  
Managed Care ◽  
Budget Impact ◽  
Diabetes Patients

Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case

2016 ◽  
Vol 23 (10) ◽  
pp. 767-779 ◽  
Author(s):  
S. Deuffic-Burban ◽  
D. Obach ◽  
V. Canva ◽  
S. Pol ◽  
F. Roudot-Thoraval ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Hepatitis C ◽  
Budget Impact ◽  
Hepatitis C Treatment ◽  
Direct Acting Antiviral ◽  
French Case ◽  
Direct Acting

scholarly journals PIN13 FIVE-YEAR BUDGET IMPACT AND LIFETIME COST EFFECTIVENESS OF A LOPINAVIR/RITONAVIR (LVP/r) VS.A NELFINAVIR (NFV) CONTAINING REGIMEN FOR TREATMENT-NAÏVE PATIENTS

2002 ◽  
Vol 5 (6) ◽  
pp. 566
Author(s):  
KN Simpson ◽  
E Chumney ◽  
MP Luo ◽  
B Bernstein ◽  
E Sun ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Budget Impact ◽  
Lifetime Cost ◽  
Treatment Naïve

Effect of PD-L1 testing on the cost-effectiveness and budget impact of pembrolizumab for advanced urothelial carcinoma of the bladder in the United States

2019 ◽  
Vol 37 (3) ◽  
pp. 180.e11-180.e18
Author(s):  
Steven D. Criss ◽  
Davis T. Weaver ◽  
Deirdre F. Sheehan ◽  
Richard J. Lee ◽  
Pari V. Pandharipande ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
Urothelial Carcinoma ◽  
Budget Impact ◽  
The United States ◽  
Carcinoma Of The Bladder ◽  
Advanced Urothelial Carcinoma ◽  
Effect Of Pd ◽  
The Cost
Sign in / Sign up

Export Citation Format

Share Document